For years, the pancreas has been being taught in biology class as an easy system: insulin lowers blood sugar, and glucagon raises it. But that’s much too simple, new research says.

This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

Glucagon-like peptide-1 drugs appear to slow the speed at which alcohol enters the bloodstream, which diminishes its effects ...

Preliminary study shows GLP-1 receptor agonists alter alcohol response, suggesting potential for reducing cravings and ...

Stories like Mendosa’s have become commonplace in the age of Ozempic. According to a 2024 Kaiser Family Foundation survey, ...

GLP-1 is a natural human hormone that regulates blood glucose levels. Scientists have now created long-lasting GLP-1 drugs ...

Weight-loss drugs like Ozempic and Zepbound appear to reduce alcohol cravings, but doctors have been at a loss to explain why ...

The situation Ray Deshaies, PhD, and Amgen faced was whether to move forward in development and commercialization a molecule ...

Innovative obesity drugs. Quantum computing bits. A cystic fibrosis treatment. The scientists behind these discoveries could ...

Drug candidates spanning oncology, neurology, rare diseases and more are approaching critical development as the calendar turns to 2026.